Novo Nordisk Settles TM Suit Against Clinic Over Compounds

By Bonnie Eslinger · June 17, 2025, 10:35 PM EDT

Novo Nordisk, the company behind drugs Ozempic, Rybelsus and Wegovy, struck a deal with an Ohio clinic to end its federal trademark infringement case, one of a slew of suits the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Novo Nordisk A/S et al v. Solace Integrative Mental Health LLC

Case Number

Court

Ohio Southern

Nature of Suit

Trademark

Date Filed

November 08, 2024

Recent Articles By Bonnie

June 06, 2025
Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand
June 02, 2025
9th Circ. Sends Express Scripts Opioid Case To State Court
May 29, 2025
Masimo Founder Slaps Board With Lawsuit Over His Ouster
May 22, 2025
Sutter Health's $228.5M Antitrust Deal Gets Initial OK
May 01, 2025
Couple's J&J Pelvic Mesh Claims Too Late, 11th Circ. Affirms
April 18, 2025
Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA
April 16, 2025
Blue Shield Of California Sued Over Google's Patient Data Use
April 11, 2025
Amgen Can't Ditch Regeneron's Bundling Antitrust Suit
April 10, 2025
Holmes Seeks Full 9th Circ. Review Of Theranos Fraud Appeal
April 02, 2025
NIH Sued By Researchers Over 'Ideological Purge' On Grants